Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Royal Victoria Eye and Ear Hospital | OTHER_GOV |
| Cochlear | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Reducing power consumption in the cochlear implant is crucial to the development of future smaller sound processors. The commercial MP3000 sound coding strategy has been shown to be more efficient in power consumption to the standard ACE strategy. However in order to develop smaller sound processors, further battery life power savings are required. The aim of this study is to evaluate three experimental sets of MP3000 parameter sets, compared against the default ACE program. In the background for each of the four strategies, experimental noise reduction programs (SpatialNR and NR3) will also be in use. In an additional phase of the study, low stimulation rate ACE programs will also be evaluated against the default stimulation rate.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MP3000-ACE strategy | Experimental | MP3000 sound coding strategy or ACE strategy with lower stimulation rate |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MP3000 sound coding strategy or ACE strategy with lower stimulation | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Word recognition scores in quiet | Word recognition scores in quiet for i) MP3000 strategy compared to default ACE strategy and ii) lower rate stimulation for ACE strategy | Testing over 18 weeks |
| Sentence recognition scores in quiet | Sentence recognition scores in quiet for i) MP3000 strategy compared to ACE strategy and ii) lower rate stimulation for ACE strategy | Testing over 18 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Fundamental frequency (F0) discrimination | F0 discrimination for MP3000 strategy compared to the ACE baseline | Testing over 18 weeks |
| Speech intelligibility and helpfulness subjective ratings | For MP3000 strategy compared to the default ACE baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The HEARing CRC | Melbourne | Victoria | 3002 | Australia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D034381 | Hearing Loss |
| ID | Term |
|---|---|
| D006311 | Hearing Disorders |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D012678 | Sensation Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Testing over 18 weeks |
| Sentence in noise scores | Comparison of MP3000 program with Spatial NR and NR3 enabled versus disabled. | Testing over 18 weeks |
| D009461 |
| Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |